Dae Gyun Ahn

Title: Dae Gyun Ahn: Innovator in Intracellular Delivery Systems

Introduction

Dae Gyun Ahn is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for intracellular delivery systems. His work focuses on enhancing the efficiency of delivering various materials into cells, which has important implications for medical and pharmaceutical applications.

Latest Patents

Dae Gyun Ahn holds a patent for a transmembrane domain derived from the human LRRC24 protein. This invention relates to a transmembrane domain known as the LRRC24P transmembrane domain, which can be utilized as a cell-penetrating peptide. The technology enables the effective delivery of cargo materials, including compounds, biomolecules, and various polymer materials, into cells. The LRRC24P transmembrane domain demonstrates higher cell penetration efficiency compared to conventional cell-penetrating peptides. Additionally, since it is derived from human proteins, it minimizes the risk of side effects and immune responses associated with foreign protein-derived peptides.

Career Highlights

Dae Gyun Ahn is affiliated with the Korea Research Institute of Chemical Technology, where he conducts research and development in the field of chemical technology and biotechnology. His innovative work has positioned him as a key figure in advancing intracellular delivery methods.

Collaborations

Dae Gyun Ahn collaborates with notable colleagues, including Seong Jun Kim and Kyun Do Kim. Their combined expertise contributes to the ongoing research and development efforts in their respective fields.

Conclusion

Dae Gyun Ahn's contributions to the field of biotechnology, particularly through his patented transmembrane domain, highlight the potential for improved intracellular delivery systems. His work not only advances scientific knowledge but also paves the way for future innovations in medical applications.